Mednet Logo
HomeDermatologyQuestion

What is your approach for severe SCLE in patients unable to tolerate HCQ?

4
3 Answers
Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)
  1. 30% of subacute cutaneous lupus erythematosus (SCLE) is worsened by or caused by drugs, especially PPIs, calcium channel blockers (CCBs), thiazides, minocycline, and anti-fungal meds. Very different from other drug-induced disorders, the culprit drug could have been started months to years (as long...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Dermatology · University of Pennsylvania

I would make sure they are not taking a drug that could cause SCLE, like omeprazole or another PPI. You could try methotrexate or mycophenolate mofetil. Anifrolumab would probably work but is hard to get unless the patient has SLE. Lenalidomide is a thalidomide derivative that works well for very re...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · University of Nevada - Las Vegas

I have found that adding 15-25 mg/week sc Methotrexate works very well for SCLE that is insufficiently responsive to HCQ or for patients unable to take HCQ. Failing that, anifrolumab provided the patient has sufficient SLE criteria to access it.

With regard to HCQ intolerance, whether it be GI intol...

Register or Sign In to see full answer

What is your approach for severe SCLE in patients unable to tolerate HCQ? | Mednet